Skip to content

The application of low-dose esketamine in cesarean section with Preeclampsia: a randomized controlled trial.

The application of low-dose esketamine in cesarean section with Preeclampsia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036189
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-08-24
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

GroupA:placebo
GroupB:S - ketamine 0.025mg/kg
GroupC:S - ketamine 0.05mg/kg
GroupD:S - ketamine 0.125mg/kg

Sponsors

International Peace Maternal and Child Health Care Institute affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Pre-eclampsia patients aged 20-50 years; 2. ASA level 2~3; 3. Who are required to undergo cesarean section; 4. Patients requiring cesarean section.

Exclusion criteria

Exclusion criteria: 1. Maternal patients with contraindications to spinal anesthesia excluded; 2. Extreme obesity (BMI >= 32) and other pregnancy complications were excluded. 3. Alcohol, substance abuse and a history of mental illness; 4. Height less than 150cm, body mass greater than 100kg, gestational age less than 36 weeks.

Design outcomes

Primary

MeasureTime frame
vital signs;VAS scores;Sedation scores;Mental symptoms;Apgar scores;Fetal umbilical cord blood gas;

Secondary

MeasureTime frame
TNF-a, IL-6, IL-10;

Countries

China

Contacts

Public ContactZeyong Yang

International Peace Maternal and Child Health care institute affiliated to Shanghai Jiaotong University School of Medicine

zeyongy2018@aliyun.com+86 13381827292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026